Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide

DNA methyltransferases (DNMTs) are responsible for DNA methylation, an epigenetic modification involved in gene regulation. Families of conjugates of procainamide, an inhibitor of DNMT1, were conceived and produced by rapid synthetic pathways. Six compounds resulted in potent inhibitors of the murine catalytic Dnmt3A/3L complex and of human DNMT1, at least 50 times greater than that of the parent compounds. The inhibitors showed selectivity for C5 DNA methyltransferases. The cytotoxicity of the inhibitors was validated on two tumour cell lines (DU145 and HCT116) and correlated with the DNMT inhibitory potency. The inhibition potency of procainamide conjugated to phthalimide through alkyl linkers depended on the length of the linker; the dodecane linker was the best.

[1]  Y. Pommier,et al.  Sequence‐specific targeting of IGF‐I and IGF‐IR genes by camptothecins , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Takayoshi Suzuki,et al.  Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[3]  Kenny K H Ang,et al.  Divergent modes of enzyme inhibition in a homologous structure-activity series. , 2009, Journal of medicinal chemistry.

[4]  Robert S Illingworth,et al.  CpG islands – ‘A rough guide’ , 2009, FEBS letters.

[5]  Nadine H. Elowe,et al.  Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[6]  J. Medina-Franco,et al.  Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1 , 2009, ChemMedChem.

[7]  A. Shilatifard,et al.  An operational definition of epigenetics. , 2009, Genes & development.

[8]  M. Szyf Epigenetics, DNA methylation, and chromatin modifying drugs. , 2009, Annual review of pharmacology and toxicology.

[9]  A. Jeltsch,et al.  Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins. , 2008, Molecular bioSystems.

[10]  Ming-Rong Wang,et al.  Anticancer drug discovery targeting DNA hypermethylation. , 2008, Current medicinal chemistry.

[11]  P. Arimondo,et al.  Targeting MDR1 Gene: Synthesis and Cellular Study of Modified Daunomycin-Triplex-Forming Oligonucleotide Conjugates Able to Inhibit Gene Expression in Resistant Cell Lines , 2008, Molecular Pharmacology.

[12]  E. Novellino,et al.  Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1. , 2008, Journal of medicinal chemistry.

[13]  M. Esteller Epigenetics in cancer. , 2008, The New England journal of medicine.

[14]  R. Blumenthal,et al.  Mammalian DNA methyltransferases: a structural perspective. , 2008, Structure.

[15]  Xiaodong Cheng,et al.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation , 2007, Nature.

[16]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[17]  Brian K Shoichet,et al.  A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.

[18]  Xiaodong Cheng,et al.  Structure and substrate recognition of the Escherichia coli DNA adenine methyltransferase. , 2006, Journal of molecular biology.

[19]  N. Osheroff,et al.  Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides , 2006, Nucleic acids research.

[20]  H. Stopper,et al.  Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. , 2006, Cancer research.

[21]  Ralf Schirrmacher,et al.  Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases. , 2006, Bioconjugate chemistry.

[22]  Byron H. Lee,et al.  Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1* , 2005, Journal of Biological Chemistry.

[23]  Frank Lyko,et al.  Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. , 2005, Cancer research.

[24]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[25]  T. Kan,et al.  Ns strategies: a highly versatile synthetic method for amines. , 2004, Chemical communications.

[26]  Manel Esteller,et al.  Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. , 2003, Cancer research.

[27]  C. Chung,et al.  Effect of detergent on "promiscuous" inhibitors. , 2003, Journal of medicinal chemistry.

[28]  M. Kuwahara,et al.  Design and Optimization of Camptothecin Conjugates of Triple Helix-forming Oligonucleotides for Sequence-specific DNA Cleavage by Topoisomerase I* , 2002, The Journal of Biological Chemistry.

[29]  C. Bailly,et al.  Directing topoisomerase I mediated DNA cleavage to specific sites by camptothecin tethered to minor- and major-groove ligands. , 2001, Angewandte Chemie.

[30]  A. Jeltsch,et al.  Biotin-Avidin Microplate Assay for the Quantitative Analysis of Enzymatic Methylation of DNA by DNA Methyltransferases , 2000, Biological chemistry.

[31]  S. Hanash,et al.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.

[32]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[33]  Lucia Altucci,et al.  Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. , 2009, The international journal of biochemistry & cell biology.

[34]  Fabienne Dioury,et al.  Synthesis of a tricyclic tetraazatriacetic ligand for gadolinium(III) as potential contrast agent for MRI , 2007 .

[35]  A. Jeltsch Molecular enzymology of mammalian DNA methyltransferases. , 2006, Current topics in microbiology and immunology.

[36]  Peter A. Jones,et al.  Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.